IVE ETF Factor Report

Validea's fundamental report on the iShares S&P 500 Value Index Fund ETF (IVE) indicates a strong emphasis on low volatility (score of 88) and value (score of 62), with moderate quality (score of 54) and weaker momentum (score of 38). The ETF, categorized as large-cap, is heavily weighted in the Financial sector and Biotechnology & Drugs industry, reflecting its value-oriented investment strategy.

Analysis

The iShares S&P 500 Value Index Fund ETF (IVE) exhibits a distinct factor profile characterized by a very strong exposure to low volatility, scoring 88 out of 99. This is complemented by a notable tilt towards value, with a score of 62. Conversely, the fund shows a weak exposure to momentum at 38 and a moderate quality score of 54. This quantitative breakdown suggests the ETF is structured to capture returns from undervalued large-cap equities while simultaneously aiming to dampen portfolio volatility, rather than chasing market trends. The fund's portfolio construction, with the Financial sector as its largest holding and Biotechnology & Drugs as its largest industry, aligns with this value-centric and defensive positioning. The moderate quality score indicates a potential trade-off, where the screening for value may not exclusively capture companies with the strongest balance sheets or most stable earnings.

Key Decisions for Investors

• Investors seeking to reduce portfolio volatility and add a defensive, value-oriented tilt to their U.S. large-cap holdings should consider IVE, given its high low volatility score of 88.
• Due to its weak momentum score of 38, this ETF may underperform in strongly trending markets and is not suitable for strategies aiming to capture short-term, growth-driven rallies.
• Portfolio managers should be mindful of the fund's significant concentration in the Financial and Biotechnology & Drugs sectors, and assess any potential overexposure to industry-specific risks.